These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8166549)

  • 1. ATP reduces blood loss produced by heparin in cardiopulmonary bypass operations.
    Garcia HV; Buffolo E; Nader HB; Dietrich CP
    Ann Thorac Surg; 1994 Apr; 57(4):956-9. PubMed ID: 8166549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin rebound: a comparative study of protamine chloride and protamine sulfate in patients undergoing coronary artery bypass surgery.
    Kuitunen AH; Salmenperä MT; Heinonen J; Rasi VP; Myllylä G
    J Cardiothorac Vasc Anesth; 1991 Jun; 5(3):221-6. PubMed ID: 1863741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
    Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass.
    Teoh KH; Young E; Bradley CA; Hirsh J
    Circulation; 1993 Nov; 88(5 Pt 2):II420-5. PubMed ID: 8222188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations.
    Jobes DR; Aitken GL; Shaffer GW
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):36-45. PubMed ID: 7609566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polybrene neutralization as a means of monitoring heparin therapy for extracoporeal cirulation.
    Foster ED; Spector JI; Talarico L; Umlas J; Valeri CR; Dobnick DB; Berger RL
    Ann Thorac Surg; 1977 Jun; 23(6):514-9. PubMed ID: 301378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial.
    Arsenault KA; Paikin JS; Hirsh J; Dale B; Whitlock RP; Teoh K; Young E; Ginsberg JS; Weitz JI; Eikelboom JW
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):944-950.e3. PubMed ID: 22743176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin rebound: a comparative study of protamine sulfate and protamine chloride in CABG surgery.
    Kuitunen A; Salmenperä M; Heinonen J; Rasi V; Myllylä G
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):81. PubMed ID: 2521014
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass.
    Shigeta O; Kojima H; Hiramatsu Y; Jikuya T; Terada Y; Atsumi N; Sakakibara Y; Nagasawa T; Mitsui T
    J Thorac Cardiovasc Surg; 1999 Aug; 118(2):354-60. PubMed ID: 10425010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin and Protamine Titration Does Not Improve Haemostasis after Cardiac Surgery: A Prospective Randomized Study.
    Radulovic V; Laffin A; Hansson KM; Backlund E; Baghaei F; Jeppsson A
    PLoS One; 2015; 10(7):e0130271. PubMed ID: 26134993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
    Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring heparin anticoagulation and its neutralization.
    Jobes DR; Schwartz AJ; Ellison N; Andrews R; Ruffini RA; Ruffini JJ
    Ann Thorac Surg; 1981 Feb; 31(2):161-6. PubMed ID: 6970019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
    Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two protocols for heparin neutralization by protamine after cardiopulmonary bypass.
    Arén C; Feddersen K; Rådegran K
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):539-41. PubMed ID: 3309479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
    Shore-Lesserson L; Reich DL; DePerio M
    Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.